IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)

NCT06647862 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia

Interventions

DRUG: IMM01
DRUG: Azacitidine
DRUG: Placebo

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.